Polaryx Therapeutics, Inc. (PLYX) Q1 2026 Earnings
PLYX·Reported May 15, 2026·Before market open
Diluted EPS came in at $-0.05, missed the $-0.02 consensus by $0.03.
Diluted EPS
$-0.05missed by $0.03
Consensus: $-0.02
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Polaryx Therapeutics, Inc. 's Q1 2026 earnings report.
Polaryx Therapeutics, Inc. (PLYX) reported Q1 2026 earnings on May 15, 2026 before market open.
Polaryx Therapeutics, Inc. reported diluted EPS of $-0.05 for Q1 2026.
EPS missed the consensus estimate of $-0.02 by $0.03.
You can read the 10-Q periodic report (0001213900-26-056973) directly on SEC EDGAR. The filing index links above go to sec.gov.